Prof. Ewa Obuchowicz, Medical University of Silesia, Poland
Prof. Ewa Obuchowicz is the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia. She earned her M.Sc. in 1979, Ph.D. in 1985, became an Associate Professor in 2001, and a Professor in 2011. Her research focuses on psychotropic drugs, neuropeptides, cytokines, and glioblastoma therapy ๐ง ๐ฌ. She has authored 89 scientific papers, with over 2,000 citations and an h-index of 20. A recipient of multiple awards ๐, she is an esteemed member of the Polish Pharmacological Society.
Publication Profile
Scopus
Education
Prof. Ewa Obuchowicz ๐ is a distinguished expert in pharmacology, with an impressive academic journey spanning decades. She earned her M.Sc. in 1979, followed by a Ph.D. in 1985, and attained full professorship in 2011. As the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia ๐ฅ, she exemplifies leadership and dedication to advancing medical research. Her extensive contributions and unwavering commitment to the field make her a strong candidate for the Best Researcher Award ๐, highlighting her impact on academia and scientific progress.
Experienceย
Prof. Ewa Obuchowicz ๐ฌ is a renowned researcher specializing in psychotropic drug mechanisms, neuropeptides, cytokines, and glial cell protein expression. Her work delves into the complex interplay between stress, immunostimulation, and neurotrophic factors ๐ง , shedding light on crucial neurological processes. Additionally, she has explored the role of the endocannabinoid system ๐ฟ and contributed to developing innovative adjuvant therapies for glioblastoma ๐๏ธ. Her groundbreaking research plays a vital role in advancing medical and pharmacological sciences, solidifying her reputation as a distinguished scientist in the field. Her dedication continues to shape the future of neuropharmacology and therapeutic innovation.
Scientific Achievements
Prof. Ewa Obuchowicz ๐ has made a remarkable impact on the scientific community with 89 full-length publications, 71 of which have been cited over 2,000 times. With an h-index of 20 (Scopus) ๐, her research has gained widespread recognition. Notably, five of her papers have been cited over 100 times, highlighting their profound influence. Beyond research articles, she has contributed to authoritative pharmacology handbooks ๐, further solidifying her scholarly excellence. Her outstanding publication record and significant contributions to the field make her a deserving candidate for the award ๐, reflecting her dedication to advancing pharmacological sciences.
Professional Memberships
Prof. Ewa Obuchowicz ๐ค is an active member of the Polish Pharmacological Society, where she contributes to professional discussions and advancements in pharmacology. Through her engagement with research organizations ๐๏ธ, she fosters collaboration and drives progressive scientific discoveries. Her dedication to the field extends beyond her own research, as she actively participates in shaping the future of pharmacology through knowledge exchange and professional networking. By staying at the forefront of scientific discourse, she continuously enhances the impact of her work, reinforcing her role as a key contributor to the advancement of medical and pharmacological sciences.
Awards
Prof. Ewa Obuchowicz ๐
has received prestigious recognition for her outstanding contributions to medical and pharmacological research. She has been honored with two Scientific Awards from the Minister of Health and Social Welfare ๐ and thirteen Scientific Awards from the Rector of the Medical University of Silesia in Katowice ๐๏ธ. These accolades reflect her dedication, innovation, and impact in the field. Her groundbreaking research and scholarly achievements continue to shape the future of pharmacology, further solidifying her candidacy for the Best Researcher Award ๐
and reinforcing her status as a leading figure in medical science.
Research Focus
Professor Ewa Obuchowicz is a distinguished neuroscientist specializing in psychopharmacology ๐ง ๐, with a research focus on depression, stress, and the endocannabinoid system. Her work explores the mechanisms of antidepressants, particularly escitalopram, and their effects on neurotransmission, gene expression, and behavioral responses. She has contributed significantly to preclinical models of stress and mood disorders, investigating the role of neuropeptides, oxytocin, and the hypothalamus-pituitary-gonadal (HPG) axis ๐ฌ๐. Additionally, her research extends to neuro-oncology, examining glioblastoma treatments. Through her studies, she aims to advance mental health therapeutics and improve understanding of stress-induced disorders.
Publication Top Notes
Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress
Acute Stress Affects the Relaxin/Insulin-Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats
How depression and antidepressant drugs affect endocannabinoid system?โreview of clinical and preclinical studies
A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies
Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats.
Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders
Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone
May application of oxytocin be relevant in the therapy of perinatal mental disorders?